Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN110627673A reveals asymmetric reduction for Formoterol intermediate. Enhances chiral purity and supply chain reliability for pharmaceutical manufacturing.
Patent CN113461773A reveals a high-yield liquid phase route for LKP tripeptide. Discover cost-effective manufacturing strategies for ACE inhibitory peptides.
Novel patent CN120004703B offers high-purity honokiol derivatives via mild conditions. Reliable supplier for scalable pharmaceutical intermediate manufacturing with cost efficiency.
Patent CN103980134A reveals high-purity S-metoprolol synthesis. Enhanced ee value and scalable process offer significant supply chain stability.
Novel two-step route avoids liquid HF. High purity >99.9%. Cost-effective API intermediate manufacturing for antiviral drugs.
Patent CN114989058B reveals a metal-free catalytic route for high-purity chiral chlorosulfoximines, offering significant cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Novel Raney Nickel route for cis-3-amino-2-arylpyrrolidine derivatives. High yield, mild conditions, scalable API intermediate manufacturing solution.
Novel two-step fluorination route for 5-fluorocytosine. High purity >99.9%, cost-effective, avoids HF. Ideal for API manufacturing.
Novel chiral allylation method for Me-tapentadol intermediates. High ee, scalable process for reliable pharmaceutical intermediate supply chain.
Patent CN114213384B reveals a ruthenium-catalyzed route for isocoumarins. This method offers significant supply chain stability and cost reduction advantages.
Novel patent CN102617506B enables cost-effective Cefdinir production. High yield, scalable process for reliable pharmaceutical intermediate supply chain partners.
Patent CN102617506B reveals a novel Cefdinir synthesis route using methylsulfonyl chloride, offering high purity and cost reduction in API manufacturing for global supply chains.
Novel patent CN116120201A enables cost-effective Iobitridol production. Enhanced yield and supply chain reliability for global pharmaceutical manufacturers.
Patent CN106831765B reveals Rh-catalyzed nitrilation for high-purity pharmaceutical intermediate manufacturing with enhanced supply chain reliability and cost efficiency.
Novel patent CN112390749B details high-yield Cabozantinib synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel patent CN105801475B details high-yield Sorafenib Tosylate preparation. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing partners.
Novel deuterium exchange synthesis for L-Aspartic acid 3 3 D2 ensures high purity and cost efficiency for stable isotope labeling applications in pharmaceutical research and development.
Patent CN111763222B reveals a green route for edoxaban free base. Eliminate Pd catalysts and genotoxic impurities for cost-effective API manufacturing.
Novel Pd/C catalyzed route from Androstenedione offers high yield and cost efficiency for steroid hormone intermediates, replacing hazardous lithium reduction.
High-yield electrochemical method for phenanthridone intermediate. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing partners globally.